Clinical Trials Insight: 700032082

Trial Profile

Clinical Trials Insight: 700032082

Planning
Phase of Trial: Phase I

Latest Information Update: 01 Apr 2008

At a glance

  • Drugs ARI 2243 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Arisaph Pharmaceuticals
  • Most Recent Events

    • 01 Apr 2008 New trial record.
    • 11 Mar 2008 The trial is expected to be initiated in the first half of 2008.
    • 11 Mar 2008 US FDA accepted Investigational New Drug application.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top